Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults

ConditionVaccination
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorJohns Hopkins Bloomberg School of Public Health

About this trial

This study will compare the use of informational videos only, personal story videos only, and the combination of both, to see which is most effective in increasing vaccination among older adults.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

U.S. adults aged 50 and older

Disqualifiers

Participants who do not complete the survey

Participants who are unable or refuse to view and listen to videos on the participant's device

Trial design

Design model

Parallel

Treatments tested in this trial

  • Informational Animation Video

    Behavioral

    The informational animation video will also take several minutes and will cover human papillomavirus (HPV) disease, address specific concerns when identified, and the importance and safety of HPV vaccines.

  • Personal Narrative Video

    Behavioral

    Personal narrative videos will consist of someone describing the person's own personal experience with HPV. The investigators have a collection of videos of personal narratives from different people that the investigators have cut to approximate several minutes in length so the investigators can tailor the personal narratives to match each study participant's race/ethnicity and gender as closely as possible.

Treatment groups

6,000 Participants
are divided into 5 treatment groups
Group A: ControlNo intervention 0 interventions
Group B: Animation OnlyExperimental treatment 1 intervention
Group C: Narrative OnlyExperimental treatment 1 intervention
Group D: Narrative Then AnimationExperimental treatment 2 interventions
Group E: Animation Then NarrativeExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Number of participants who receive vaccine

Vaccination status. Binary variables (received vs not received) for each vaccine recommended for older adults

Time frame
9-month follow-up

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.